The Use of Combined Motor Imagery and Action Observation to Evaluate the Influence on Functional Parameters Such as Strength, Range of Motion, Pain or Fear of Movement Among Others, in Females Breast Cancer Survivors.
NCT ID: NCT07067710
Last Updated: 2025-07-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
108 participants
INTERVENTIONAL
2025-02-25
2026-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Nerve Mobilization Techniques After Breast Cancer Surgery
NCT03250351
The Recovery of Reaching Movement in Breast Cancer Survivors: Two Different Rehabilitative Protocols in Comparison
NCT04166279
Effectiveness of a Therapeutic Exercise Program With Specific Upper Limb Exercises to Reduce Lymphedema and Neuropathy in Breast Cancer Patients: A Pre-post Study (LYNMA)
NCT07170631
Muscle Oxygen Saturation and Functional Capacity in Breast Cancer Survivors
NCT06976593
Effect of Telemonitoring on Functionality, Quality of Life and Risk of Lymphedema in Breast Cancer Survivors
NCT04779450
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Methods: A randomised controlled clinical trial will be conducted. Subjects will be randomly assigned to the two randomly assigned to the two treatment groups: intervention (IM-OA23 programme) and control group (usual care).
This study will have pre and post measurements. The intervention consist on a display of diferent videos of upper limb movements and at daily living activities and in a excercise of imagine and doing this movements. The're will be used diferent tools such as a dynamometer, a goniometer, Visual Analogue Scale (VAS) of pain, or TSK questionnaire.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
IMOA group
The intervention group will participate in the IM-OA23 programme; the combination of motor imagery and action observation therapies.
Motor imagery combined with action observation
To observe and imaging one action with a video resource. Not virtual reality.
Control group
The control group will follow the usual care from primary care. There are no care programmes for long term cancer survivors.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Motor imagery combined with action observation
To observe and imaging one action with a video resource. Not virtual reality.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Instituto de Investigación Sanitaria de Navarra (IdiSNA)
UNKNOWN
Fundacion Miguel Servet
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Paula Escalada-Hernández, PhD
Role: STUDY_DIRECTOR
Public University of Navarra
Nelia Soto-Ruiz, PhD
Role: STUDY_DIRECTOR
Universidad Pública de Navarra
Pilar Arnal-Vallés, Candidate PhD
Role: PRINCIPAL_INVESTIGATOR
Hospital of Navarra
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Public University of Navarre
Pamplona, Navarre, Spain
Public University of Navarre
Pamplona, Navarre, Spain
Public University of Navarre
Pamplona, Navarre, Spain
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PI_2023/81
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
PI_2023/81 Programa IM-OA23
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.